NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that it will be sponsoring the World Conference on Regenerative Medicine to be held on October 29-31, 2009 in Leipzig, Germany. The conference, which will be organized by the Fraunhofer Institute for Cell Therapy and Immunology, will provide a platform for the exchange of information on stem cells, tissue engineering, technology development such as bioreactors, immunology signaling and regulatory topics.
